It's going to take gold until the end of the year to rally to $2,000 an ounce, said Phil Streible, chief market strategist of Blue Line Futures.
Green copper demand to average 13% annual growth over next 10 years – report
As the pace and shape of the green transition are fast becoming one of the key themes for the global economy, copper will experience a surge in demand over 2021-2030, earning a spot on market analyst Fitch Solutions’ list of commodities of the future.
The Mental Health Pandemic Soars Into Focus, Psychedelics In The Spotlight
As the Mental Health Pandemic spirals out of control, we see a positive sign: the mainstream media has finally noticed it.
Gold and silver trade higher leading into the European open
Gold and silver are starting off the new week on the front foot.
Russia prepares to hit metals firms with $2.3bn in export taxes
Russia is preparing new export taxes for steel products, nickel, aluminium and copper which will cost their producers $2.3 billion between Aug. 1 and Dec. 31, its officials told a government meeting on Thursday.
MindMed Included in FTSE Russell 3000® Index
MindMed officially announces its inclusion in the FTSE Russell 3000.
Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and Adelia Milestone Achievement
In pre-clinical testing, multiple proprietary molecules "showed consistent positive results when compared to the parent molecule".
COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression
Compass Pathways completes the world's largest psilocybin-based clinical trial as the 216th patient in its trial completed their treatment.
Nine In Ten Texas Voters Support Legalizing Marijuana In Some Form, Poll Finds
Nearly nine out of ten Texas voters say marijuana should be legal in some form, with just 13 percent still backing prohibition, according to a new poll.
Cybin Inc. Releases Annual Financials and Provides Business Highlights
Cybin Inc releases its full-year financial results for the fiscal year ended March 31, 2021 and provides business highlights.
Psyched Wellness Commences Next Pre-Clinical Study on AME-1
Psyched Wellness announces its latest pre-clinical study on AME-1.
Field Trip Health Ltd. Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results
Field Trip reports Q4 and full-year results for fiscal 2021. Cash position of CAD$111m. Clinic revenues increased by 63% q-o-q to CAD$526,435.